19:42 , Nov 11, 2016 |  BC Week In Review  |  Company News

Bellicum, Bambino Gesu Children's Hospital deal

Bellicum and the hospital partnered to jointly develop CAR T cell and T cell receptor (TCR) therapies discovered by the hospital and engineered with Bellicum’s CaspaCIDe molecular safety switch technology. Bellicum will provide up to...
07:00 , Oct 8, 2012 |  BioCentury  |  Product Development

Boosting mitochondria

Edison Pharmaceuticals Inc. plans to bring EPI-743 into Phase IIb testing this quarter after leveraging insights gained from an expanded access protocol to score a positive Phase IIa result in Leigh disease. The company is...